| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |